Reinitiation of Abilify Maintena 400 mg After 1-Year Gap
For a patient who previously tolerated Abilify Maintena but has been off it for one year, you must restart using either the 1-day or 14-day initiation protocol exactly as if they were a new patient—there is no abbreviated restart option after this long of a gap. 1
Critical FDA Guidance on Missed Doses
The FDA label is explicit about this scenario: if more than 6 weeks have elapsed since the last injection (which clearly applies after 1 year), you must restart treatment with either the 1-day or 14-day initiation regimen. 1 This is not optional—the pharmacokinetics require full reinitiation to achieve therapeutic levels safely.
Two Initiation Options
You have two evidence-based choices:
Option 1: Two-Injection Start (1-Day Initiation)
- Administer two separate 400 mg IM injections on Day 1 in different injection sites (deltoid and/or gluteal—do NOT inject both in the same muscle)
- Plus one 20 mg oral aripiprazole dose on Day 1
- No additional oral supplementation needed 1
Option 2: Single-Injection Start (14-Day Initiation)
- Administer one 400 mg IM injection (deltoid or gluteal)
- Plus oral aripiprazole 10-20 mg daily for 14 consecutive days 1
Which Initiation Method to Choose?
The two-injection start (1-day) regimen is increasingly preferred in clinical practice based on recent evidence showing:
- Comparable safety profile to the 14-day regimen with no increased adverse effects 2, 3
- Shorter hospitalization times (8.1 vs 11.8 days in one study) 3
- Lower rehospitalization rates within 1 year (17.0% vs 37.5%) 3
- Better adherence by eliminating the need for 14 days of oral supplementation 4, 5
- Serum levels within therapeutic window without peaks above the window that may occur with the 14-day regimen 4
- Faster clinical recovery particularly in acute episodes 5
The two-injection start is now approved by the European Medicines Agency and is supported by population pharmacokinetic modeling 6 and multiple real-world studies 2, 3, 5, 7.
Important Caveats
Before any initiation:
- Confirm prior tolerability to aripiprazole. Since this patient took Abilify Maintena previously, tolerability is already established—you do NOT need to restart oral aripiprazole for 2 weeks first 1
- Check for CYP2D6 poor metabolizer status or use of strong CYP3A4/CYP2D6 inhibitors, which require dose reduction to 300 mg 1
Common barriers to the two-injection start include patient reluctance about receiving two injections on the same day (reported by 66% of clinicians) 7, but this can be addressed through patient education about the benefits of avoiding 14 days of oral medication.
Maintenance Dosing
After successful initiation with either method, continue with 400 mg IM monthly (no sooner than 26 days between injections). The dose can be reduced to 300 mg monthly if adverse reactions occur 1.